For research use only. PeptaBase is for informational and laboratory research reference only. No medical claims are made and nothing on this site is intended to diagnose, treat, cure or prevent any disease.
PeptaBase
500+ PubMed CitationsFree To UseNo Account Required
Back to Database
Longevity & Mitochondrial

MOTS-C Protocol

Dosing & Research

Last Updated: September 4, 2026

Chemical Identity
Amino Acid Sequence
Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
Molecular Formula
C101H152N28O22S2
Molecular Weight
2174.6 g/mol
CAS Number
1627580-64-6

Exercise mimetic research, Insulin sensitivity, Mitochondrial stress adaptation, Healthy aging studies

Evidence Level
Animal Models Primary
Species Studied
Human • Mouse • Rat
Half-Life
~4 Hours (estimated)
Administration
Subcutaneous
Frequency
3x weekly (weeks 1-4 initial); 1x weekly (weeks 5-8 maintenance)

How It Works

  • Exercise mimetic research
  • Insulin sensitivity
  • Mitochondrial stress adaptation
  • Healthy aging studies

Dosing Structure

Dose
1 mg 3-5x weekly
Frequency
3x weekly (weeks 1-4 initial); 1x weekly (weeks 5-8 maintenance)
Notes
Initial Stage (Weeks 1-4): 5mg taken 3 times per week. Maintenance Stage (Weeks 5-8): 5mg taken 1 time per week. Cycle: 8 weeks with 4-week break. For more aggressive protocols, consider increasing doses to 10mg. Do not stack with AICAR. Inject: Abdomen, thigh, upper arm (rotate). Morning before exercise. Break: 2-4 weeks between continuous cycles.

Example Protocols

Dose: 1 mg 3-5x weekly
Frequency: 3x weekly (weeks 1-4 initial); 1x weekly (weeks 5-8 maintenance)
Duration: 6-8 weeks
Off Period: Not listed
Calculate dosing →

Find Research Grade MOTS-C

Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.

Vendor One Research Labs

COA Verified

Third-party COA-verified research peptides with published batch testing.

Source Coming Soon

Vendor Two Sciences

Purity Tested

US-based research compound supplier with independent purity testing.

Source Coming Soon

Vendor Three Peptide Co.

Bulk research peptide sourcing with batch-level documentation.

Source Coming Soon
View all recommended vendors →

Protocol Notes

Initial Stage (Weeks 1-4): 5mg taken 3 times per week.
Maintenance Stage (Weeks 5-8): 5mg taken 1 time per week.
Cycle: 8 weeks with 4-week break.
For more aggressive protocols, consider increasing doses to 10mg.
Do not stack with AICAR.
Inject: Abdomen, thigh, upper arm (rotate).
Morning before exercise.
Break: 2-4 weeks between continuous cycles.

What Is MOTS-C?

MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome - making it one of the few known mitochondria-derived peptides (MDPs). It functions as a mitokine: a hormone-like signal secreted by mitochondria in response to metabolic stress that communicates with the nucleus and systemic tissues. Research focuses on its role in insulin sensitivity, metabolic regulation, exercise mimicry, and longevity.

Research Observations - Not Medical Claims
  • Insulin sensitivity: MOTS-c administration in mice on a high-fat diet significantly improved insulin sensitivity and reduced fat accumulation - effects were comparable to metformin in the same model (PMID: 25735772).
  • Exercise mimicry: MOTS-c increases with aerobic exercise in humans. Exogenous MOTS-c injection in aged mice improved exercise capacity and muscle function - proposed as a potential exercise-mimetic compound (PMID: 31004536).
  • Longevity association: MOTS-c levels decline with aging. Genetic variants in the MOTS-c locus are associated with longevity in Japanese centenarian populations (PMID: 25735772).
  • Nuclear translocation: Under metabolic stress, MOTS-c translocates to the nucleus and regulates gene expression - a unique mechanism among peptide hormones (PMID: 31485084).
  • Metabolic inflammation: MOTS-c reduces inflammatory cytokines (TNF-α, IL-6) in adipose tissue and liver in metabolic disease models.

Evidence Summary

Animal Models PrimaryResearch Chemical - no regulatory approval; not approved for human therapeutic use
Evidence StrengthPreliminary
PreliminaryModerateStrong
Curated Citations3
Most Recent Study2024
Species Studied
HumanMouseRat

Commonly Researched With

Epithalon
Both are studied in longevity and anti-aging research; MOTS-c for mitochondrial/metabolic function, Epithalon for telomere maintenance.
NAD+
MOTS-c and NAD+ both target mitochondrial function and metabolic efficiency - studied together in aging and metabolic disease research.
Ipamorelin
GH secretagogues and MOTS-c are both studied in body composition and metabolic contexts as complementary mechanisms.

Research & Studies

Loading citations…

Research Feedback

0 approved

For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.

Related Peptides

Epithalon
Longevity & Mitochondrial
FOXO4-DRI
Longevity & Mitochondrial
Glutathione
Longevity & Mitochondrial
Humanin
Longevity & Mitochondrial